Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket

Shares of Salarius Pharmaceuticals, Inc. SLRX rose sharply in today’s pre-market trading following fourth-quarter results.

Salarius Pharmaceuticals posted a net loss of $0.9 million, or 22 cents per share for the fourth quarter, narrower than the year-ago loss of $6.4 million, or $2.83 per share, according to data from Benzinga Pro.

Salarius Pharmaceuticals shares jumped 31.4% to $0.8149 in pre-market trading

Here are some other stocks moving in pre-market trading.


  • Next.e.GO N.V. EGOX shares rose 85.8% to $0.0730 in pre-market trading after falling around 22% on Friday.
  • MicroAlgo Inc. MLGO rose 56.7% to $6.30 in pre-market trading after declining around 5% on Friday.
  • Forge Global Holdings, Inc. FRGE shares gained 22.8% to $2.86 in pre-market trading after gaining 13% on Friday.
  • Canopy Growth Corporation CGC gained 19.5% to $9.17 in pre-market trading. The German government approved legislation which legalizes the possession and cultivation of cannabis beginning April 1.
  • Flora Growth Corp. FLGC shares rose 17.7% to $1.86 in pre-market trading after surging around 34% on Friday.
  • Cazoo Group Ltd CZOO gained 17.3% to $4.35 in pre-market trading after declining around 21% on Friday.
  • Biophytis S.A. BPTS climbed 17.1% to $0.4471 in pre-market trading. Biophytis recently presented its Phase 3 protocol of RuvembriTM in the treatment of Sarcopenia at the ICFSR.
  • Recon Technology, Ltd. RCON shares rose 14.5% to $0.1570 in pre-market trading.
  • Esperion Therapeutics, Inc. ESPR gained 12.7% to $2.58 in pre-market trading as the U.S. FDA approved broad new labels for Esperion's NEXLETOL® and NEXLIZET® to prevent heart attacks and cardiovascular procedures in both primary and secondary prevention patients, regardless of statin use.


  • Sintx Technologies, Inc. SINT dipped 29.7% to $0.0650 in pre-market trading. SINTX Technologies shares dipped 32% on Friday after the company announced a proposed public offering of common stock.
  • Invivyd, Inc. IVVD declined 14.8% to $3.72 in pre-market trading. Invivyd shares jumped 41% on Friday after the company announced that PEMGARDA received emergency use authorization from the FDA for the pre-exposure prophylaxis of COVID-19.
  • Greenlane Holdings, Inc. GNLN fell 10.8% to $0.52 pre-market trading after jumping around 11% on Friday.
  • BYND Cannasoft Enterprises Inc. BCAN fell 10.8% to $2.24 pre-market trading after dipping 31% on Friday.
  • Mangoceuticals, Inc. MGRX shares tumbled 9.7% to $0.1688 in pre-market trading after declining around 5% on Friday.
  • Australian Oilseeds Holdings Limited COOT fell 8.5% to $2.27 in pre-market trading after falling over 22% on Friday.
  • Ontrak, Inc. OTRK fell 8.2% to $0.36 in pre-market trading after jumping around 50% on Friday.
  • Murano Global Investments Plc MRNO shares fell 7.6% to $19.64 in pre-market trading amid volatility following the company's recently completed business combination with HCM Acquisition Corp and Nasdaq debut last week.
  • Laser Photonics Corporation LASE shares fell 6.5% to $1.73 in pre-market trading after dipping around 9% on Friday. Laser Photonics, last week, announced a distribution agreement with Incredible Supply & Logistics (ISL) for its military and industrial laser solutions.
  • OKYO Pharma Limited OKYO shares tumbled 6.2% to $1.44 after falling around 13% on Friday. OKYO Pharma, last week, announced additional key findings from analyses of the clinical data set from the 240-patient Phase 2 trial evaluating the safety and efficacy of OK-101 (0.05%) ophthalmic solution in patients with dry eye disease (DED).


Now Read This: Top 5 Consumer Stocks That May Crash This Month

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!